There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
To determine the direct costs of therapy over 5 years of a European monotherapy cohort
begun on a prostaglandin (PTG) versus timolol in patients with primary open-angle
glaucoma or ocular hypertension.